Lipopolysaccharide-Binding Protein Downregulates Fractalkine through Activation of p38 MAPK and NF-κB

Xia Huang1,2, Yi Zeng3, Yujie Jiang1,2

  • 1The First Clinical Medical College of Jinan University, Guangzhou, Guangdong Province 510630, China.

Abstract

Insights

Lipopolysaccharide (LPS) increases lipopolysaccharide-binding protein (LBP) and decreases fractalkine in acute respiratory distress syndrome (ARDS). LBP activation of p38 MAPK and NF-κB pathways downregulates fractalkine, contributing to ARDS pathogenesis.

Area of Science:

  • Pulmonary Medicine
  • Cell Biology
  • Molecular Biology

Background:

  • Lipopolysaccharide-binding protein (LBP) and fractalkine are implicated in acute respiratory distress syndrome (ARDS) pathogenesis.
  • This study investigates the interplay between LBP and fractalkine in lipopolysaccharide (LPS)-induced ARDS models.

Purpose of the Study:

  • To elucidate the regulatory role of LBP in fractalkine expression within LPS-induced cellular and animal models of ARDS.
  • To explore the involvement of p38 MAPK and p65 NF-κB signaling pathways in LBP-mediated fractalkine modulation.

Main Methods:

  • Utilized A549 cells and an LPS-induced ARDS rat model.
  • Employed techniques including RT-PCR, western blotting, ELISA, immunofluorescence, co-immunoprecipitation, and immunohistochemistry.
  • Investigated the effects of LBP manipulation (overexpression, silencing) and pathway inhibitors (SB203580, SC-514) on fractalkine, LBP, p38 MAPK, and p65 NF-κB.

Main Results:

  • LPS treatment upregulated LBP and downregulated fractalkine in both A549 cells and rat lungs.
  • LBP overexpression exacerbated fractalkine downregulation, while LBP silencing, SB203580, and SC-514 reversed this effect.
  • In vivo, LBPK95A, SB203580, and SC-514 treatments attenuated lung injury and normalized fractalkine levels by inhibiting phospho-p38 MAPK and p65 NF-κB.

Conclusions:

  • LBP downregulates fractalkine expression in LPS-induced ARDS.
  • This downregulation is mediated through the activation of p38 MAPK and NF-κB signaling pathways.
  • Targeting LBP or these pathways may offer therapeutic strategies for ARDS.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.1K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.4K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.9K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
18.7K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.7K
Formation of Lipopolysaccharides01:19

Formation of Lipopolysaccharides

Lipopolysaccharides (LPS) are crucial components of the outer membrane of Gram-negative bacteria, serving both structural and functional roles. It contributes to membrane stability and protects bacteria from host immune responses. LPS is composed of three major regions—lipid A, a core oligosaccharide, and an O antigen. The biosynthesis and assembly of LPS involve a highly coordinated set of enzymatic reactions and transport mechanisms. Additionally, LPS is recognized as an endotoxin,...
784